RTC North, University College of London (UCL), and EU Japan Center, which are the partners of European Commission, have organized Japan tour with more than 10 companies/organizations leading the field of gene therapy, in time with Medical Japan 2018 in Osaka. Supported by Innovate UK and Enterprise Europe Network(EEN), LINK-J will host pitch event and reception party in Nihonbashi with the British Embassy, with aim to support and provide an opportunity for further growth to all attendees.
Date and Time:
February 20, 2018（TUE）18:00-20:00
Venue:
Nihonbashi Life Science HUB (1-5-5, Nihonbashi Muromachi, Chuo-ku, Tokyo 103-0022 8F., Muromachi Chibagin Mitsui Building)
Program
17:30～ Opening
18:00～19:00 Company presentation
19:00～20:00 Reception
【Company Profile】*It may be changed
・Bayly Simon (Business Development Manager at Oxford MEStar Ltd / England, United Kingdom)
・Blyth Alex (CEO at LIfT BioSciences Ltd / England, United Kingdom)
・Theoharis Stefanos (SVP Corporate Development and Partnering at Cell Medica / London, United Kingdom)
・Corbau Romuald (VP Research at Freeline Therapeutics / Stevenage, United Kingdom)
・Lakelin Matthew (VP Scientific Affairs at TrakCel Ltd. / Wales, United Kingdom)
・Rees Claudia (Operations Director at Cells4Life Group LLP / Burgess Hill, United Kingdom)
・Bloor steve (CEO at Videregen Limited / Liverpool, United Kingdom)
・Themis Michael(Reader, Scientist. TestaVec Founder at TestaVec Ltd)
・Lane Jonathan (CEO at Nanogenic Solutions Ltd / Loxwood, United Kingdom)
・Theobald Nigel (CEO at N4 Pharma Plc / England, United Kingdom)
・Mazza Giuseppe (Co-Founder and CEO at Engitix Ltd / England, United Kingdom)
・Najafi Mitra (Managing Director and Founder at Pplus Skin Care Ltd/England, United Kingdom)
・McLean Michael (CEO at Atelerix Ltd / Babraham, United Kingdom)
Participation fee
Free
Organizer
LINK-J
Contact
LINK-J
TEL：03-3241-4911（AM9：00～PM5：00）
E-mail：contact@link-j.org